BG60833B2 - Теофилин-лекарствена форма с удължено действие - Google Patents

Теофилин-лекарствена форма с удължено действие Download PDF

Info

Publication number
BG60833B2
BG60833B2 BG098598A BG9859894A BG60833B2 BG 60833 B2 BG60833 B2 BG 60833B2 BG 098598 A BG098598 A BG 098598A BG 9859894 A BG9859894 A BG 9859894A BG 60833 B2 BG60833 B2 BG 60833B2
Authority
BG
Bulgaria
Prior art keywords
theophylline
dosage form
matrix pellets
pellets
matrix
Prior art date
Application number
BG098598A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerald Benedikt
Volker Steinijans
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BG60833B2 publication Critical patent/BG60833B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
BG098598A 1984-12-21 1994-02-28 Теофилин-лекарствена форма с удължено действие BG60833B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH268385 1985-06-24

Publications (1)

Publication Number Publication Date
BG60833B2 true BG60833B2 (bg) 1996-04-30

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098598A BG60833B2 (bg) 1984-12-21 1994-02-28 Теофилин-лекарствена форма с удължено действие

Country Status (20)

Country Link
US (1) US4803080A (enExample)
EP (1) EP0185331B1 (enExample)
KR (1) KR920006910B1 (enExample)
CN (1) CN1008060B (enExample)
AU (1) AU581274B2 (enExample)
BG (1) BG60833B2 (enExample)
CA (1) CA1261268A (enExample)
CS (1) CS396391A3 (enExample)
DE (1) DE3572924D1 (enExample)
DK (1) DK164843C (enExample)
ES (1) ES8704079A1 (enExample)
FI (1) FI84782C (enExample)
GR (1) GR853051B (enExample)
HU (1) HU193359B (enExample)
IE (1) IE58246B1 (enExample)
IL (1) IL77322A (enExample)
NO (1) NO171827C (enExample)
NZ (1) NZ214534A (enExample)
PT (1) PT81714B (enExample)
SK (1) SK278868B6 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
AU2005325930B2 (en) * 2005-01-27 2012-01-19 Alembic Limited Extended release formulation of Levetiracetam
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
MX2014000419A (es) 2011-07-15 2014-09-22 Nusirt Sciences Inc Composicones y metodos para modular trayectorias metabolicas.
BR112015010947A2 (en) 2012-11-13 2018-06-05 Nusirt Sciences, Inc. compositions and methods for increasing energy metabolism.
JP2016505023A (ja) 2013-01-15 2016-02-18 ニューサート サイエンシーズ， インコーポレイテッド 肺の状態の処置
SG11201507046UA (en) 2013-03-15 2015-10-29 Nusirt Sciences Inc Leucine and nicotinic acid reduces lipid levels
CA2939833A1 (en) 2014-02-27 2015-09-03 Nusirt Sciences, Inc. Compositions and methods for the reduction or prevention of hepatic steatosis
JP6826730B2 (ja) * 2015-04-16 2021-02-10 学校法人 関西大学 抗氷核活性剤
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (en) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1091289B (de) * 1956-01-25 1960-10-20 Hans Lowey Verfahren zur Herstellung einer oral anzuwendenden Arzneiform mit verlaengerter Wirkungsdauer
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
WO1983000284A1 (en) * 1981-07-15 1983-02-03 Key Pharma Sustained release theophylline
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
IL77322A (en) 1990-07-12
FI84782C (fi) 1992-01-27
DK164843C (da) 1993-01-11
FI854973A0 (fi) 1985-12-16
SK278868B6 (sk) 1998-04-08
PT81714B (pt) 1988-04-21
CA1261268A (en) 1989-09-26
US4803080A (en) 1989-02-07
NZ214534A (en) 1988-08-30
KR860004634A (ko) 1986-07-11
NO171827B (no) 1993-02-01
DK600485A (da) 1986-06-22
AU581274B2 (en) 1989-02-16
CS396391A3 (en) 1992-06-17
HU193359B (en) 1987-09-28
NO855215L (no) 1986-06-23
NO171827C (no) 1993-05-12
DE3572924D1 (en) 1989-10-19
DK600485D0 (da) 1985-12-20
IE58246B1 (en) 1993-08-11
ES8704079A1 (es) 1987-04-01
HUT40334A (en) 1986-12-28
KR920006910B1 (ko) 1992-08-22
PT81714A (de) 1986-01-01
CN85109688A (zh) 1986-06-10
CN1008060B (zh) 1990-05-23
EP0185331B1 (de) 1989-09-13
DK164843B (da) 1992-08-31
ES550291A0 (es) 1987-04-01
FI854973L (fi) 1986-06-22
AU5161885A (en) 1986-07-17
FI84782B (fi) 1991-10-15
GR853051B (enExample) 1986-02-03
EP0185331A1 (de) 1986-06-25
IE853107L (en) 1986-06-21

Similar Documents

Publication Publication Date Title
EP0164967B1 (en) Pharmaceutical composition of sparingly soluble medicament and method for its preparation
RU2201223C2 (ru) Фармацевтическая композиция из множества субъединиц и способ ее получения
CA2042289C (en) Taste masking and sustained release coatings for pharmaceuticals
JP4976011B2 (ja) 制御放出モルヒネ製剤
FI84782C (fi) Foerfarande foer framstaellning av ett teofyllinpreparat med foerlaengd verkan.
US5670171A (en) Liquid-suspension controlled-release pharmaceutical composition
CA2038245C (en) Pharmaceutically useful micropellets
US4717713A (en) Controlled release liquid pharmaceutical
US4851226A (en) Chewable medicament tablet containing means for taste masking
US4443428A (en) Extended action controlled release compositions
FR2494112A1 (enExample)
JPS5859916A (ja) ブロモヘキシンの遅延放出剤型およびその製造方法
JPS6116368B2 (enExample)
JPH10502390A (ja) 医薬品用の徐放性マトリックス
JP2599189B2 (ja) 味覚遮蔽剤を含有している咀嚼可能な薬物錠剤
US4966770A (en) Prednisone microencapsulated granules
EP0083372B1 (en) Sustained release theophyline
JPH082783B2 (ja) 新規な投与形態
EP0063132A1 (fr) Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme.
JPH0417932B2 (enExample)
CN115837012A (zh) 一种氨氯地平干混悬剂及其制备方法
US5344657A (en) Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
CA1336326C (en) Microbeads of diltiazem, a process for their manufacture and a sustained-release pharmaceutical composition containing them
CN111214454B (zh) 一种防止析晶的单硝酸异山梨酯缓释微丸及其制备方法
JPH0474331B2 (enExample)